The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...
HOUSTON (Reuters) - US regulators have approved the expansion of Cheniere's Corpus Christi liquefied natural gas (LNG) plant ...
Instylla, Inc. announced that it recently submitted the final module of its premarket approval (PMA) application to the FDA ...
Siemens unveiled the two photon-counting CTs in December. GE HealthCare and Philips Healthcare are developing their own ...
It’s time to revamp the FDA’s “generally recognized as safe,” or GRAS, program that allows companies to add untested ...
“I am very pleased with the new FDA approval goal date of June 4, 2025 for our Ketamine drug. We are focused on solving the shortage issue of Ketamine and becoming the leading supplier of Ketamine to ...
PharmaTher (PHRRF) has received an Amendment Acknowledgement Letter from the U.S. Food and Drug Administration for its New Drug Application for ...
Miach Orthopaedics's BEAR implant is now cleared for treating complete and partial ACL tears in children of any age.
Miach Orthopaedics announced today that the FDA cleared an expanded indication for the company's Bear implant for ACL tears.
Miach Orthopaedics' BEAR (bridge-enhanced ACL restoration) implant is now available to treat children and adolescents with anterior cruciate ligament tears afte ...
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...